City Holding Co’s Novo Nordisk NVO Stock Holding History

City Holding Co’s Portfolio NVO Stock Details NVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.44K	Hold	51	–	–	﹤0.01%	566
2026 Q1	$1.87K	Hold	51	–	–	﹤0.01%	553
2025 Q4	$2.59K	Hold	51	–	–	﹤0.01%	562
2025 Q3	$2.83K	Buy	+51	New	+$2.98K	﹤0.01%	558
2023 Q4	–	Sell	-1,306	Closed	-$119K	–	512
2023 Q3	$119K	Hold	1,306	–	–	0.02%	248
2023 Q2	$106K	Buy	+1,306	New	+$107K	0.02%	265
2018 Q3	–	Sell	-186	Closed	-$4K	–	542
2018 Q2	$4K	Hold	186	–	–	﹤0.01%	462
2018 Q1	$5K	Hold	186	–	–	﹤0.01%	456
2017 Q4	$5K	Hold	186	–	–	﹤0.01%	467
2017 Q3	$4K	Buy	+186	New	+$4.2K	﹤0.01%	488
2016 Q4	–	Sell	-276	Closed	-$6K	–	561
2016 Q3	$6K	Hold	276	–	–	﹤0.01%	417
2016 Q2	$7K	Buy	+276	New	+$7.57K	﹤0.01%	410
2014 Q3	–	Sell	-600	Closed	-$14K	–	420
2014 Q2	$14K	Hold	600	–	–	0.01%	325
2014 Q1	$14K	Hold	600	–	–	0.01%	310
2013 Q4	$11K	Buy	+600	New	+$10.5K	0.01%	323

Other funds holding NVO

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

City Holding Co's NVO Position: Q2 2026 in Review

City Holding Co held its Novo Nordisk (NVO) position steady in Q2 2026 at 51 shares worth $2.44K. The position accounts for ﹤0.01% of the portfolio, ranked #566.

City Holding Co first reported a position in NVO in Q4 2013 and has held it in 15 quarters since. The position peaked at $119K in Q3 2023. 1,350 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

City Holding Co held 51 shares of Novo Nordisk worth $2.44K as of Q2 2026.
City Holding Co left its Novo Nordisk share count unchanged in Q2 2026.
Novo Nordisk made up ﹤0.01% of City Holding Co's portfolio in Q2 2026, its #566 holding.
City Holding Co first reported a position in Novo Nordisk in Q4 2013 and has held it in 15 quarters since.
City Holding Co's Novo Nordisk position peaked at $119K in Q3 2023.
1,350 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on City Holding Co's 13F filing for Q2 2026, filed 10 Jul 2026.